spike
protein
main
surfac
antigen
sarscoronaviru
sarscov
one
import
antigen
candid
vaccin
design
present
studi
three
fragment
truncat
protein
express
e
coli
analyz
pool
sera
convalesc
phase
sar
patient
full
length
gene
dna
vaccin
construct
use
immun
balbc
mice
mous
serum
igg
antibodi
sarscov
measur
elisa
e
coli
express
truncat
protein
sarscov
lysat
diagnost
antigen
result
show
three
fragment
protein
express
e
coli
abl
react
sera
sar
patient
gene
dna
candid
vaccin
could
induc
product
specif
igg
antibodi
sarscov
effici
mice
seroconvers
ratio
time
immun
find
lay
foundat
understand
immunolog
sarscov
develop
sar
vaccin
sever
acut
respiratori
syndrom
sar
also
name
infecti
atyp
pneumonia
newli
describ
highli
contagi
respiratori
infect
first
occur
late
guangdong
provinc
china
spread
countri
earli
identifi
etiolog
agent
sar
novel
coronaviru
name
sarscov
spike
protein
coronaviru
major
envelop
compon
constitut
spike
project
virion
surfac
mediat
mani
biolog
properti
viru
attach
cell
receptor
penetr
spread
virusinduc
cell
cell
fusion
protein
also
play
import
role
immun
respons
viru
sinc
neutral
antibodi
passiv
antibodi
protect
cellular
immun
relat
protein
therefor
spike
protein
may
act
potenti
antigen
sar
vaccin
design
gene
sarscov
encod
surfac
glycoprotein
precursor
predict
amino
acid
length
belong
type
membran
protein
low
level
similar
amino
acid
ident
coronavirus
present
studi
truncat
fragment
sarscov
protein
express
e
coli
antigen
analyz
furthermor
candid
dna
vaccin
contain
fulllength
gene
construct
immunogen
evalu
mice
dna
fragment
si
encod
nucleotid
nt
sarscov
gene
synthes
shanghai
bioasia
biotech
compani
two
dna
fragment
sii
encod
nt
siii
encod
nt
sarscov
gene
kindli
provid
prof
zhenghong
yuan
molecular
virolog
lab
fudan
univers
nucleotid
sequenc
three
dna
fragment
ident
publish
data
genbank
access
number
expand
long
templat
pcr
system
roch
prokaryot
express
plasmid
pproex
hta
life
technolog
prokaryot
express
plasmid
e
coli
strain
product
amersham
bioscienc
ninta
affin
resin
qiagen
sera
convalesc
phase
sar
patient
collect
beij
xiaotangshan
hospit
inactiv
heat
min
elisa
kit
igg
igm
antibodi
sarscov
beij
bgigbi
biotech
co
ltd
eukaryot
express
plasmid
pcidn
construct
vector
gene
hbv
murin
gene
replac
synthet
rabbit
betaglobin
intron
sixweek
old
femal
balbc
mice
purchas
xiperbikai
experiment
anim
co
ltd
shanghai
hrp
conjug
goatantihuman
igg
goatantimous
igg
sigma
construct
prokaryot
express
plasmid
contain
fragment
gene
dna
fragment
encod
amino
acid
sarscov
protein
amplifi
use
follow
primer
saf
gaa
ttc
atg
agt
gac
ctt
gac
cgg
tgc
sar
gaa
ttc
tta
acc
tcg
agt
aac
atc
tcc
tga
ggg
aac
aac
fragment
si
use
templat
amplifi
insert
vector
subclon
ecori
site
pproex
hta
express
plasmid
identifi
ecori
psti
digest
respect
dna
fragment
encod
aa
sarscov
protein
amplifi
follow
primer
sbf
gaa
ttc
atg
gat
ttc
act
gat
tcc
gtt
cga
gat
sbr
gcg
gcc
gct
tag
gta
act
cca
atg
cca
ttg
aac
fragment
sii
use
templat
amplifi
amplifi
fragment
insert
vector
construct
express
plasmid
obtain
subclon
fragment
ecorinoti
digest
dna
fragment
encod
aa
sarscov
protein
amplifi
follow
primer
scf
gaa
ttc
atg
gga
tgg
aca
ttt
ggt
gct
ggc
gct
scr
gcg
gcc
gct
tat
tgc
tca
tat
ttt
ccc
aat
tct
fragment
sii
siii
use
templat
amplifi
soepcr
method
product
clone
vector
insert
ecorinoti
site
express
plasmid
e
coli
transform
plasmid
respect
posit
coloni
chosen
cultur
overnight
lb
medium
contain
mgl
ampicillin
cultur
dilut
time
medium
incub
reach
iptg
ad
final
concentr
mmoll
induct
express
bacteria
collect
hour
lyse
load
buffer
sdspage
analysi
antigen
express
protein
determin
western
blot
use
fold
dilut
pool
sera
convalesc
phase
two
sar
patient
primari
antibodi
fold
dilut
hrp
conjug
goatantihuman
igg
second
antibodi
dna
fragment
encod
nt
gene
amplifi
primer
nf
gaa
ttc
gct
agc
cac
cat
gtt
tat
ttt
ctt
att
att
nr
gga
tcc
tct
aga
tta
tga
act
atc
agc
acc
taa
aga
fragment
si
sii
soepcr
amplifi
fragment
insert
vector
subclon
ecoribamhi
site
eukaryot
express
plasmid
pcidn
result
plasmid
name
pcidnsa
anoth
dna
fragment
cover
nt
gene
amplifi
primer
cf
gag
ctg
agc
atg
tcg
cr
gga
tcc
tct
aga
tta
tgt
gta
atg
taa
ttt
gac
use
templat
sii
siii
clone
vector
sequenc
amplifi
dna
fragment
fuse
pcidnsa
sali
bamhi
site
eukaryot
express
plasmid
pcidnf
contain
fulllength
gene
sar
cov
obtain
plasmid
pcidnf
pcidn
prepar
mega
plasmid
prepar
kit
qiagen
dissolv
moll
pb
final
concentr
gl
sixteen
balbc
mice
randomli
divid
two
group
eight
mice
group
mice
experiment
group
inject
pcidnf
tibiali
anterior
muscl
mice
boost
twice
dosag
week
interv
mice
control
group
receiv
amount
pcidn
vector
ident
rout
frequenc
recombin
protein
purifi
ninta
affin
resin
accord
manufactur
direct
microtit
plate
coat
purifi
protein
mgl
carbon
buffer
detect
antibodi
sarscov
mous
sera
addit
microtit
plate
coat
sarscov
lysat
also
use
detect
mous
sera
collect
week
first
immun
dilut
pb
ph
contain
goat
sera
detect
antibodi
hrp
conjug
goatantimous
igg
dilut
tmbh
use
substrat
absorb
nm
measur
elisa
reader
biorad
con
mice
experiment
group
larger
equal
averag
valu
control
group
data
analyz
student
ttest
signific
differ
plasmid
encod
fusion
protein
kd
histidin
nterminu
plasmid
encod
two
fragment
truncat
protein
fuse
gst
molecular
weight
kd
kd
respect
sdspage
recombin
express
protein
could
visual
molecular
weight
predict
fig
protein
stronger
structur
dna
vaccin
pcidnf
shown
fig
p
cmv
earli
promoterenhanc
sequenc
cmv
intron
rabbit
betaglobin
intron
repres
fulllength
gene
sarscov
bgh
pa
transcript
termin
signal
bovin
growth
hormon
gene
dhfr
dihydrofol
reductas
gene
neo
neomycin
phosphotransferas
gene
three
nucleotid
mutat
found
gene
pcidnf
compar
parent
sequenc
genbank
access
number
first
one
occur
nt
c
nonsens
mutat
second
one
nt
g
result
amino
acid
ile
val
mutat
last
one
nt
lead
amino
acid
thr
ser
mutat
restrict
endonucleas
psti
site
nt
sali
site
nt
gene
sarscov
antigen
protein
fragment
express
e
coli
determin
antisarscov
igg
posit
sera
sar
patient
western
blot
shown
fig
three
truncat
protein
could
react
pool
sera
sar
patient
reactiv
protein
use
diagnost
antigen
elisa
detect
igg
antibodi
sarscov
mous
sera
posit
ratio
found
variou
time
cours
week
first
immun
pcidnf
posit
ratio
increas
serum
sampl
test
use
virion
lysat
sarscov
diagnost
antigen
sera
posit
protein
base
elisa
also
posit
virion
lysat
base
elisa
signific
differ
observ
compar
valu
elisa
detect
pcidnf
immun
group
pcidn
group
differ
develop
week
first
immun
increas
gradual
week
tabl
tabl
protein
import
infect
pathogen
coronaviru
mutat
gene
previous
correl
alter
pathogenesi
virul
tropism
coronavirus
protein
coronavirus
cleav
host
cell
trypsinlik
proteas
involv
receptor
bind
involv
cell
fusion
protein
major
target
neutral
antibodi
anim
coronavirus
also
induc
cytotox
lymphocyt
exampl
protein
mous
hepat
viru
mhv
transmiss
gastroenter
viru
tgev
could
elicit
neutral
antibodi
protect
anim
virul
viru
challeng
addit
immun
protect
subunit
nterminu
protein
potent
subunit
cterminu
howev
case
felin
infecti
periton
fipv
antibodi
protein
fipv
protect
found
antibodi
fipv
protein
enhanc
diseas
progress
antibodydepend
enhanc
ade
infect
effect
dengu
viru
virusantibodi
immun
complex
bind
monocyt
macrophag
via
fc
receptor
immunoglobulin
g
complement
receptor
cell
surfac
target
cell
sarscov
monocyt
macrophag
convalesc
sera
sar
patient
effect
clinic
treatment
sarscov
infect
therefor
ade
effect
may
occur
sarscov
present
studi
fragment
protein
sarscov
express
e
coli
antigen
recombin
protein
determin
convalesc
sera
sar
patient
antigen
found
stronger
consist
report
major
antigen
domain
locat
nterminu
protein
nterminu
subunit
coronavirus
present
result
may
reliabl
repres
distribut
epitop
sarscov
protein
two
serum
sampl
use
recombin
protein
nonglycosyl
denatur
dna
vaccin
pcidnf
contain
fulllength
gene
use
immun
balbc
mice
signific
differ
antibodi
respons
develop
dna
vaccin
group
mock
plasmid
control
group
differ
increas
boost
indic
dna
vaccin
induc
specif
humor
immun
respons
protein
sarscov
dna
vaccin
group
one
mous
gener
specif
antibodi
right
first
immun
use
virion
lysat
diagnost
antigen
detect
antibodi
sarscov
protein
dna
vaccineimmun
mice
posit
week
last
immun
posit
week
last
immun
reactiv
sarscov
virion
lysat
sensit
recombin
protein
detect
specif
antibodi
probabl
protein
nonglycosyl
natur
cover
partial
epitop
complet
protein
addit
quantiti
structur
coat
antigen
may
also
influenc
sensit
elisa
detect
specif
recombin
protein
virion
lysat
indic
antibodi
induc
dna
vaccin
specif
protein
gene
sarscov
encod
type
membran
glycoprotein
elimin
transmembran
domain
carboxyl
terminu
may
make
dna
vaccin
express
secret
protein
induc
stronger
immun
respons
case
dna
vaccin
less
effect
larger
speci
small
anim
use
much
human
antigen
produc
host
cell
dna
immun
mechan
basic
similar
recombin
inactiv
vaccin
addit
immun
stimul
vector
dna
result
also
uphold
recombin
protein
may
good
candid
antigen
sar
vaccin
design
dna
vaccin
pcidnf
contain
dihydrofol
reductas
dhfr
gene
neomycin
phosphotransferas
neo
gene
two
marker
use
select
transfect
cell
amplifi
target
gene
dna
construct
use
express
protein
sarscov
chodhfrcel
express
system
prepar
recombin
sar
vaccin
